Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report

Objective: To report the case of a 35-year-old woman with treatment-resistant aquaporin-4 (AQP-4) immunoglobulin G (IgG) seronegative neuromyelitis optica spectrum disorder (NMOSD) successfully treated with eculizumab (a terminal complement inhibitor). Methods: The investigational procedures and tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Digala, Lakshmi, Katyal, Nakul, Narula, Naureen, Govindarajan, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134535/
https://www.ncbi.nlm.nih.gov/pubmed/34025563
http://dx.doi.org/10.3389/fneur.2021.660741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134535/
https://www.ncbi.nlm.nih.gov/pubmed/34025563
http://dx.doi.org/10.3389/fneur.2021.660741

Ejemplares similares